Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 633 Records) |
| Query Trace: Disease and PIK3CA[original query] |
|---|
| Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 9 JCO2400110. Komal L Jhaveri, Melissa K Accordino, Philippe L Bedard, Andrés Cervantes, Valentina Gambardella, Erika Hamilton, Antoine Italiano, Kevin Kalinsky, Ian E Krop, Mafalda Oliveira, Peter Schmid, Cristina Saura, Nicholas C Turner, Andrea Varga, Sravanthi Cheeti, Stephanie Hilz, Katherine E Hutchinson, Yanling Jin, Stephanie Royer-Joo, Ubong Peters, Noopur Shankar, Jennifer L Schutzman, Dejan Jur |
| Endometrial carcinomas with ambiguous histology often harbor TP53 mutations. Virchows Archiv : an international journal of pathology 2024 9 . Ben Davidson, Karin Teien Lande, Daniel Nebdal, Anne Jorunn Nesbakken, Arild Holth, Kristina Lindemann, Ane Gerda Zahl Eriksson, Therese Sørl |
| PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2- breast cancer. Cancer medicine 2024 9 13 (17): e70101. Eduardo Terán, Rebeca Lozano, César A Rodríguez, Mar Abad, Luis Figuero, José Antonio Muñoz, Belén Cigarral, Aline Rodrígues, Magdalena Sancho, M Asunción Gómez, Daniel Morchón, Juan Carlos Montero, José María Sayagués, M Dolores Ludeña, Emilio Fonse |
| Determination of the frequency and distribution of APC, PIK3CA, and SMAD4 gene mutations in Ugandan patients with colorectal cancer. BMC cancer 2024 9 24 (1): 1212. Richard Wismayer, Rosie Matthews, Celina Whalley, Julius Kiwanuka, Fredrick Elishama Kakembo, Steve Thorn, Henry Wabinga, Michael Odida, Ian Tomlins |
| The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches. Oncology research 2024 9 32 (9): 1407-1422. Rossana Roncato, Jerry Polesel, Federica Tosi, Elena Peruzzi, Erika Brugugnoli, Claudia Lauria Pantano, Maria Furfaro, Filippo DI Girolamo, Alessandro Nani, Arianna Pani, Noemi Milan, Elena DE Mattia, Andrea Sartore-Bianchi, Erika Cecch |
| Somatic and germline mutations in endometrial cancer. Journal of medicine and life 2024 9 17 (6): 564-573. Robert Botea, Madalina Piron-Dumitrascu, Tiberiu Augustin Georgescu, Camil Laurentiu Bohiltea, Silviu Cristian Voinea, Valentin Nicolae Varlas, Simona Raluca Iacoban, Nicolae Suc |
| [Genetic Analysis of Cerebrovascular Diseases]. No shinkei geka. Neurological surgery 2024 9 52 (5): 1057-1081. Satoru Miyawaki, Hiroki Hongo, Seiei Torazawa, Shotaro Ogawa, Nobuhito Sai |
| Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer Survival. JAMA oncology 2024 9 . Mahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, Mohammad M Fanaeian, Mark Knafl, Jennifer Peterson, Mohammad Zeineddine, Kristin Alfaro, Fadl Zeineddine, Drew Goldstein, Nicholas Hornstein, Arvind Dasari, Ryan Huey, Benny Johnson, Victoria Higbie, Alisha Bent, Bryan Kee, Michael Lee, Maria Pia Morelli, Van Karlyle Morris, Daniel Halperin, Michael J Overman, Christine Parseghian, Eduardo Vilar, Robert Wolff, Kanwal P Raghav, Michael G White, Abhineet Uppal, Ryan Sun, Wenyi Wang, Scott Kopetz, Jason Willis, John Paul Sh |
| Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2024 8 195 107917. Akihiro Tamiya, Mitsuo Osuga, Daijiro Harada, Shun-Ichi Isa, Yoshihiko Taniguchi, Keiichi Nakamura, Yasuyuki Mizumori, Tsutomu Shinohara, Hidetoshi Yanai, Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako, Koji Yamazaki, Atsuhisa Tamura, Masahiko Ando, Yasuhiro K |
| Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers. BMC cancer 2024 8 24 (1): 951. Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina, Diego Ampuero, Liliana Ramos, Paola Pérez, Osvaldo Aren, Sara Chernilo, Cristina Fernández, María Loreto Spencer, Jacqueline Flores Aguila, Giuliano Bernal Dossetto, Mónica Ahumada Olea, Germán Rasse, Carolina Sánchez, Maria Galli de Amorim, Thais F Bartelli, Diana Noronha Nunes, Emmanuel Dias-Neto, Helano C Freitas, Ricardo Armis |
| Identification of breast cancer-associated PIK3CA H1047R mutation in blood circulation using an asymmetric PCR assay. PloS one 2024 8 19 (8): e0309209. Dinh Thi Thao, Nguyen Phu Thanh, Dong Van Quyen, Ly Tuan Khai, Le Huu Song, Ngo Tat Tru |
| Detection of HPV DNA in Saliva of Patients with HPV-Associated Oropharyngeal Cancer Treated with Radiotherapy. Current oncology (Toronto, Ont.) 2024 8 31 (8): 4397-4405. Atsushi Motegi, Shun-Ichiro Kageyama, Yukie Kashima, Hidenari Hirata, Hidehiro Hojo, Masaki Nakamura, Takeshi Fujisawa, Tomohiro Enokida, Makoto Tahara, Kazuto Matsuura, Sadamoto Zen |
| Genomic landscape of gallbladder cancer: insights from whole exome sequencing. International journal of surgery (London, England) 2024 8 . Supriya Awasthi, Rahul Kumar, Dibyabhaba Pradhan, Neetu Rawal, Harsh Goel, Parameswar Sahu, Sandeep Sisodiya, Rashmi Rana, Sunil Kumar, Nihar Ranjan Dash, Prasenjit Das, Usha Agrawal, G K Rath, Tanvir Kaur, R S Dhaliwal, Showket Hussain, Sundeep Singh Saluja, Pranay Tanw |
| Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines. Cell reports 2024 8 43 (8): 114616. Anne Huber, Amr H Allam, Christine Dijkstra, Stefan Thiem, Jennifer Huynh, Ashleigh R Poh, Joshua Konecnik, Saumya P Jacob, Rita Busuttil, Yang Liao, David Chisanga, Wei Shi, Mariah G Alorro, Stephen Forrow, Daniele V F Tauriello, Eduard Batlle, Alex Boussioutas, David S Williams, Michael Buchert, Matthias Ernst, Moritz F Eissma |
| Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer. International journal of cancer 2024 8 . Charlotte K Kindt, Carla L Alves, Sidse Ehmsen, Amalie Kragh, Thomas Reinert, Marianne Vogsen, Annette R Kodahl, Jeanette D Rønlev, Dilan Ardik, Anna L Sørensen, Kirstine Evald, Mia L Clemmensen, Johan Staaf, Henrik J Ditz |
| Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma. Gynecologic oncology 2024 8 189 138-145. Han T Cun, Laurence Bernard, Karin Teien Lande, Barrett C Lawson, Anne-Jorunn Nesbakken, Ben Davidson, Kristina Lindemann, Bryan Fellman, Therese Sørlie, Pamela T Soliman, Ane Gerda Zahl Erikss |
| Whole-exome sequencing of vulvar squamous cell carcinomas reveals an impaired prognosis in patients with TP53 mutations and concurrent CCND1 gains. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2024 8 100574. Oriol Ordi, Adela Saco, Nuria Peñuelas, Odei Blanco-Irazuegui, Marta Del Pino, Núria Carreras-Dieguez, Lorena Marimon, Maria Teresa Rodrigo-Calvo, Alba Morató, Lia Sisuashvili, Mariona Bustamante, Adrià Cruells, Katarzyna Darecka, Naiara Vega, Silvia Alós, Isabel Trias, Pere Fusté, Genis Parra, Marta Gut, Meritxell Munmany, Aureli Torné, Pedro Jares, Natalia Rakislo |
| Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data. Translational lung cancer research 2024 7 13 (6): 1296-1306. Sheng Lu, Aotian Guo, Haichuan Hu, Xinxin Ying, Yao Li, Zhengwei Huang, Wangjue Xu, Shen Tao, Xiaotong Hu, Na Yan, Xuan Zhang, Dan Shen, Takaaki Sasaki, Surein Arulananda, Ken Onodera, Zhengfu |
| Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma. Hepatology international 2024 7 . Makoto Chuma, Haruki Uojima, Hidenori Toyoda, Atsushi Hiraoka, Yoshitake Arase, Masanori Atsukawa, Norio Itokawa, Tomomi Okubo, Toshifumi Tada, Kazushi Numata, Manabu Morimoto, Makoto Sugimori, Akito Nozaki, Shuichiro Iwasaki, Satoshi Yasuda, Yuichi Koshiyama, Yusuke Mishima, Kota Tsuruya, Chikako Tokoro, Yuki Miura, Hisashi Hidaka, Takashi Kumada, Chika Kusano, Tatehiro Kagawa, Shin Mae |
| Ipatasertib plus Paclitaxel for patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 7 . Rebecca A Dent, Sung-Bae Kim, Mafalda Oliveira, Carlos Barrios, Joyce O'Shaughnessy, Steven J Isakoff, Shigehira Saji, Ruffo Freitas-Junior, Manuel Philco, Igor Bondarenko, Qinshu Lian, Denise Bradley, Heather Hinton, Matthew J Wongchenko, Sarah-Jayne Reilly, Nicholas Turn |
| NGS mutational status on first diagnostic tissue, liquid biopsy and mastectomy in G2-G3 breast cancer. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2024 7 65 (2): 195-201. Carmen Maria Ardeleanu, Maria Victoria Olinca, Cristian Gabriel Vii?oreanu, Hora?iu Alin Mure?an, Adriana Tecuceanu-Vulpe, Georgiana Manole, Iulia Elena Gune, Bianca G?l??eanu, Andreea Corina Ilie-Petrov, Flavia Ultimes |
| Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer. Prostate cancer and prostatic diseases 2024 7 . Amanda Broderick, Elizabeth Pan, Jinju Li, Alec Chu, Clara Hwang, Pedro C Barata, Frank Cameron Cackowski, Matthew Labriola, Alyssa Ghose, Mehmet Asim Bilen, Deepak Kilari, Bicky Thapa, Michael Piero, Laura Graham, Abhishek Tripathi, Rohan Garje, Vadim S Koshkin, Erik Hernandez, Tanya B Dorff, Michael Thomas Schweizer, Ajjai Shivaram Alva, Rana R McKay, Andrew J Armstro |
| Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysis. Frontiers in oncology 2024 6 14 1408664. Marcin Kubeczko, Anna Polakiewicz-Gilowska, Katarzyna ?widerska, Aleksandra Le?niak, Marta Mianowska-Malec, Barbarba ?anoszka, Konstanty Chomik, Barbara Grandys, Natalya Lisovska, Barbara Bobek-Billewicz, Ewa Chmielik, Micha? Jarz |
| Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer. Cancer medicine 2024 6 13 (12): e7384. Shang-Hung Chen, Ka-Po Tse, Yen-Jung Lu, Shu-Jen Chen, Yu-Feng Tian, Kien Thiam Tan, Chien-Feng |
| Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study. The Lancet. Oncology 2024 12 25 (12): e629-e638. Hope S Rugo, Florence Lerebours, Eva Ciruelos, Pamela Drullinsky, Manuel Ruiz-Borrego, Patrick Neven, Yeon Hee Park, Aleix Prat, Thomas Bachelot, Dejan Juric, Nicholas Turner, Nickolas Sophos, Juan Pablo Zarate, Christina Arce, Yu-Ming Shen, Stuart Turner, Hemanth Kanakamedala, Wei-Chun Hsu, Stephen Ch |
| Mutational Landscape of Gastric Adenocarcinoma of the Fundic Gland Type Revealed by Whole Genome Sequencing. Cancer medicine 2024 10 13 (19): e70290. Hu Wei, Ze Min Chen, Xiu Fen Xue, Li Xia Xi, Gen Hua Yang, Zhi Yong Zhai, Zhao Yu Huang, Ping Zhou, Chong Ju Bao, Li Juan You, Mei Ping Ou Yang, Gui Li Xia, Zhi Yu Zeng, Xiao Bing Cui, Xiao Juan Pei, Wei Go |
| Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy. Journal of translational medicine 2024 10 22 (1): 969. François Bertucci, Arnaud Guille, Florence Lerebours, Michele Ceccarelli, Najeeb Syed, José Adélaïde, Pascal Finetti, Naoto T Ueno, Steven Van Laere, Patrice Viens, Alexandre De Nonneville, Anthony Goncalves, Daniel Birnbaum, Céline Callens, Davide Bedognetti, Emilie Mamessi |
| A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors. Biomedicines 2024 10 12 (10): . Alessandra Virga, Caterina Gianni, Michela Palleschi, Davide Angeli, Filippo Merloni, Roberta Maltoni, Paola Ulivi, Giovanni Martinelli, Ugo De Giorgi, Sara Bravacci |
| Clinical and Histopathological Features of Thyroid Cancer with TERT Promoter Molecular Alterations in Isolation Versus with Concurrent Molecular Alterations: A Multicenter Retrospective Study. Cancers 2024 10 16 (20): . Emily Steinberg, Orr Dimitstein, Grégoire B Morand, Véronique-Isabelle Forest, Sabrina D da Silva, Marc Pusztaszeri, Sama Alohali, Richard J Pay |
| Associations between PIK3CA Mutations and Disease Free Survival in Patients with HR+, HER2- Tumors Treated with Adjuvant Hormonal Therapy: A Real-World Study in Croatia. The breast journal 2025 1 2024 5648845. Dora ?erina Pavlinovi?, Natalija Dedi? Plaveti?, Ingrid Belac Lovasi?, Robert Šeparovi?, Josipa Flam, Marija Pancirov, Žarko Baji?, Snježana Tomi?, Eduard Vrdolj |
- Page last reviewed:Feb 1, 2024
- Content source: